3 active not recruiting, 1 completed. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Lung Small Cell Carcinoma: new trials by email Literature Review of Lung Small Cell Carcinoma trials Research Report on Lung Small Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas Dostarlimab, Niraparib - Lung Small Cell Carcinoma, Neuroendocrine Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 48 | 2021-02-01 | 2026-10-07 |
| National Cancer Institute "Cancer Moonshot Biobank" Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Acute Myeloid Leukemia, Anatomic Stage III Breast Cancer AJCC v8 | Active not recruiting | National Cancer Institute (NCI) | 1600 | 2020-11-11 | 2026-10-05 | |
| Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer Best Practice, Cognitive Behavior Therapy, Questionnaire Administration - Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 46 | 2020-07-01 | 2024-10-31 |
| S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer Magnetic Resonance Imaging, Prophylactic Cranial Irradiation - Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma | Phase 3 | Active not recruiting | SWOG Cancer Research Network | 668 | 2020-05-04 | 2026-06-11 |
Small Cell Lung Carcinoma (4) · Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Carcinoma, Neuroendocrine (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Leukemia, Myeloid, Acute (1) · Melanoma (1) · Multiple Myeloma (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Bronchial Neoplasms (4) · Carcinoma, Bronchogenic (4) · Lung Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thoracic Neoplasms (4) · Lung Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Adenocarcinoma (1)
Magnetic Resonance Spectroscopy (2) · Cognitive Behavioral Therapy (1) · Disulfides (1) · Immunoglobulin G (1) · Paracentesis (1) · Practice Guidelines as Topic (1) · Specimen Handling (1) · Standard of Care (1) · dostarlimab (1) · niraparib (1)
M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · SWOG Cancer Research Network (1)
United States (4) · Canada (1) · Chile (1) · Colombia (1) · Mexico (1) · Puerto Rico (1) · Saudi Arabia (1) · South Korea (1)
Barbara Andersen, PhD (1) · Carl M Gay, MD,PHD (1) · Chad G Rusthoven (1) · Lyndsay N Harris (1)
U10CA180888 (1)